Full-Life Technologies, a global radiotherapeutics company, is constructing a new Good Manufacturing Practices (GMP) compliant manufacturing facility in Gembloux, Belgium, for radiopharmaceuticals. This strategic investment will enhance radiopharmaceutical production capabilities at a key logistical hub to ensure the timely supply and delivery worldwide. 
 
The 4,000 square meter, state-of-the-art facility, which will serve as Full-Life’s production hub, integrates sustainable design with automation and digital quality assurance systems. The facility, which will sit on 17,000 square meters of land, is specifically tailored to produce a broad spectrum of radiopharmaceuticals.
 
Philippe van Put, General Manager of Full-Life Technologies Europe, said, “Effective manufacturing and supply chain management are key to radiopharmaceutical development and commercialization. This facility will ensure a reliable supply for clinical development and Gembloux provides us with a distinct advantage, with its location at the heart of Europe’s biotech innovation corridor, its rich pool of professional expertise, and strong logistic network.”